Protective Role of Melatonin on Oxidative Stress Status and RNA Expression in Cerebral Cortex and Cerebellum of AβPP Transgenic Mice After Chronic Exposure to Aluminum
- 13 August 2009
- journal article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 135 (1-3) , 220-232
Abstract
Aluminum (Al) has been associated with pro-oxidant effects, as well as with various serious neurodegenerative diseases such as Alzheimer’s disease (AD). On the other hand, melatonin (Mel) is a known antioxidant, which can directly act as free radical scavenger, or indirectly by inducing the expression of some genes linked to the antioxidant defense. In this study, 5-month-old AßPP female transgenic (Tg2576) (Tg) and wild-type mice were fed with Al lactate supplemented in the diet (1 mg Al/g diet). Concurrently, animals received oral Mel (10 mg/kg) until the end of the study at 11 months of age. Four treatment groups were included for both Tg and wild-type mice: control, Al only, Mel only, and Al + Mel. At the end of the treatment period, cortex and cerebellum were removed and processed to examine the following oxidative stress markers: reduced glutathione, oxidized glutathione, cytosolic Cu–Zn superoxide dismutase (SOD1), glutathione reductase (GR), glutathione peroxidase, catalase (CAT), and thiobarbituric acid reactive substances. Moreover, the gene expression of SOD1, GR, and CAT was evaluated by real-time RT-PCR. The biochemical changes observed in cortex and cerebellum suggest that Al acted as a pro-oxidant agent. Melatonin exerted an antioxidant action by increasing the mRNA levels of the enzymes SOD1, CAT, and GR evaluated in presence of Al and Mel, independently on the animal model.Keywords
This publication has 51 references indexed in Scilit:
- Influence of age on aluminum induced lipid peroxidation and neurolipofuscin in frontal cortex of rat brain: A behavioral, biochemical and ultrastructural studyBrain Research, 2009
- Role of Metal Ions in the Aβ Oligomerization in Alzheimers Disease and in Other Neurological DisordersCurrent Alzheimer Research, 2008
- Role of medication in the level of aluminium in the blood of chronic haemodialysis patientsNephrology Dialysis Transplantation, 2008
- Melatonin reduces lipid and protein oxidative damage in synaptosomes due to aluminiumJournal of Trace Elements in Medicine and Biology, 2007
- Aluminum and other metals in Alzheimer's disease: A review of potential therapy with chelating agentsJournal of Alzheimer’s Disease, 2006
- Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegenerationJournal of Alzheimer’s Disease, 2006
- Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from waterToxicology, 2006
- Aluminum in hippocampal neurons from humans with Alzheimer's diseaseNeuroToxicology, 2006
- Severe cerebral congophilic angiopathy coincident with increased brain aluminium in a resident of Camelford, Cornwall, UKJournal of Neurology, Neurosurgery & Psychiatry, 2006
- The pro-oxidant activity of aluminumFree Radical Biology and Medicine, 2004